|
|
心力衰竭和慢性阻塞性肺疾病相互影响的研究进展
|
Abstract:
心力衰竭(Heart failure, HF)和慢性阻塞性肺疾病(Chronic obstructive pulmonary disease, COPD)的发病率及死亡率都居高不下，是全球性健康问题。有数据报道了心力衰竭患者中存在一定比例的COPD患者，部分CODP患者也会合并心力衰竭。有研究表明共患心力衰竭及COPD的患者临床预后更差、死亡率风险更高。本文拟就心力衰竭和慢性阻塞性肺疾病相互影响的研究进展及治疗进行综述。
Heart failure (HF) and chronic obstructive pulmonary disease (COPD) are global health problems with high morbidity and mortality. There are data reported that there is a certain proportion of COPD patients in patients with heart failure; some CODP patients will also be combined with heart failure. Studies have identified a poorer clinical prognosis and higher mortality risk in patients with co-existing heart failure and COPD. This article reviews the research progress and treatment of the interaction between heart failure and chronic obstructive pulmonary disease.
| [1] | Pellicori, P., Cleland, J.G.F. and Clark, A.L. (2022) Chronic Obstructive Pulmonary Disease and Heart Failure: A Breathless Conspiracy. Cardiology Clinics, 40, 171-182. https://doi.org/10.1016/j.ccl.2021.12.005 |
| [2] | Pellicori, P., Salekin, D., Pan, D., et al. (2017) This Patient Is Not Breathing Properly: Is This COPD, Heart Failure, or Neither? Expert Review of Cardiovascular Therapy, 15, 389-396. https://doi.org/10.1080/14779072.2017.1317592 |
| [3] | Larssen, M.S., Steine, K., Hilde, J.M., et al. (2017) Mechanisms of ECG Signs in Chronic Obstructive Pulmonary Disease. Open Heart, 4, e000552. https://doi.org/10.1136/openhrt-2016-000552 |
| [4] | Horodinschi, R.N., Bratu, O.G., Dediu, G.N., et al. (2020) Heart Failure and Chronic Obstructive Pulmonary Disease: A Review. Acta Cardiologica, 75, 97-104. https://doi.org/10.1080/00015385.2018.1559485 |
| [5] | Divo, M., Cote, C., De Torres, J.P., et al. (2012) Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 186, 155-161. https://doi.org/10.1164/rccm.201201-0034OC |
| [6] | Kaszuba, E., Odeberg, H., Rastam, L., et al. (2018) Impact of Heart Failure and Other Comorbidities on Mortality in Patients with Chronic Obstructive Pulmonary Disease: A Register-Based, Prospective Cohort Study. BMC Family Practice, 19, Article No. 178. https://doi.org/10.1186/s12875-018-0865-8 |
| [7] | Iversen, K.K., Kjaergaard, J., Akkan, D., et al. (2008) Chronic Obstructive Pulmonary Disease in Patients Admitted with Heart Failure. Journal of Internal Medicine, 264, 361-369. https://doi.org/10.1111/j.1365-2796.2008.01975.x |
| [8] | Hawkins, N.M., Virani, S. and Ceconi, C. (2013) Heart Failure and Chronic Obstructive Pulmonary Disease: The Challenges Facing Physicians and Health Services. European Heart Journal, 34, 2795-2803. https://doi.org/10.1093/eurheartj/eht192 |
| [9] | De Miguel Díez, J., Chancafe Morgan, J. and Jiménez García, R. (2013) The Association between COPD and Heart Failure Risk: A Review. International Journal of Chronic Obstructive Pulmonary Disease, 8, 305-312. https://doi.org/10.2147/COPD.S31236 |
| [10] | Clarenbach, C.F., Senn, O., Sievi, N.A., et al. (2013) Determinants of Endothelial Function in Patients with COPD. The European Respiratory Journal, 42, 1194-1204. https://doi.org/10.1183/09031936.00144612 |
| [11] | Eickhoff, P., Valipour, A., Kiss, D., et al. (2008) Determinants of Systemic Vascular Function in Patients with Stable Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 178, 1211-1218. https://doi.org/10.1164/rccm.200709-1412OC |
| [12] | Moro, L., Pedone, C., Scarlata, S., et al. (2008) Endothelial Dysfunction in Chronic Obstructive Pulmonary Disease. Angiology, 59, 357-364. https://doi.org/10.1177/0003319707306141 |
| [13] | Barnes, P.J. and Celli, B.R. (2009) Systemic Manifestations and Comorbidities of COPD. The European Respiratory Journal, 33, 1165-1185. https://doi.org/10.1183/09031936.00128008 |
| [14] | Woodruff, P.G., Barr, R.G., Bleecker, E., et al. (2016) Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function. The New England Journal of Medicine, 374, 1811-1821. https://doi.org/10.1056/NEJMoa1505971 |
| [15] | Regan, E.A., Lynch, D.A., Curran-Everett, D., et al. (2015) Clinical and Radiologic Disease in Smokers with Normal Spirometry. JAMA Internal Medicine, 175, 1539-1549. https://doi.org/10.1001/jamainternmed.2015.2735 |
| [16] | Zhang, J., Pellicori, P., Pan, D., et al. (2018) Dynamic Risk Stratification Using Serial Measurements of Plasma Concentrations of Natriuretic Peptides in Patients with Heart Failure. International Journal of Cardiology, 269, 196-200. https://doi.org/10.1016/j.ijcard.2018.06.070 |
| [17] | Houben-Wilke, S., Spruit, M.A., Uszko-Lencer, N., et al. (2017) Echocardiographic Abnormalities and Their Impact on Health Status in Patients with COPD Referred for Pulmonary Rehabilitation. Respirology, 22, 928-934. https://doi.org/10.1111/resp.12968 |
| [18] | Yancy, C.W., Jessup, M., Bozkurt, B., et al. (2013) 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, 62, e147-e239. |
| [19] | Ponikowski, P., Voors, A.A., Anker, S.D., et al. (2016) 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC) Developed with the Special Contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal, 37, 2129-2200. https://doi.org/10.1093/eurheartj/ehw128 |
| [20] | Canepa, M., Franssen, F.M.E., Olschewski, H., et al. (2019) Diagnostic and Therapeutic Gaps in Patients with Heart Failure and Chronic Obstructive Pulmonary Disease. JACC: Heart Failure, 7, 823-833. https://doi.org/10.1016/j.jchf.2019.05.009 |
| [21] | Wolsk, E., Claggett, B., K？ber, L., et al. (2018) Contribution of Cardiac and Extra-Cardiac Disease Burden to Risk of Cardiovascular Outcomes Varies by Ejection Fraction in Heart Failure. European Journal of Heart Failure, 20, 504-510. https://doi.org/10.1002/ejhf.1073 |
| [22] | Iorio, A., Senni, M., Barbati, G., et al., (2018) Prevalence and Prognostic Impact of Non-Cardiac Co-Morbidities in Heart Failure Outpatients with Preserved and Reduced Ejection Fraction: A Community-Based Study. European Journal of Heart Failure, 20, 1257-1266. https://doi.org/10.1002/ejhf.1202 |
| [23] | Desai, A.S., Lam, C.S.P., McMurray, J.J.V., et al. (2023) How to Manage Heart Failure with Preserved Ejection Fraction: Practical Guidance for Clinicians. JACC: Heart Failure, 11, 619-636. https://doi.org/10.1016/j.jchf.2023.03.011 |
